The AIDS Institute is pleased to announce that the third annual PrEP Aware Week will be held this year from October 25 to October 31. With your support, we anticipate that 2021 will be our most exciting and engaging PrEP Aware Week yet!
PrEP Aware Week 2021 will feature a diverse panel of community PrEP Ambassadors discussing the theme: "My PrEP.” This theme emphasizes that PrEP can be tailored to support each individual’s sexual health and HIV prevention needs. In the coming weeks you will hear more about the exciting messages that these ambassadors have developed under the theme of: “My PrEP”!
Stay tuned! In the coming weeks the AIDS Institute will share:
Details about a statewide webinar to introduce the new 2021 ambassadors and explore ideas for participating in PrEP Aware Week
A Social Media Toolkit that includes short videos, ads and posts
Email signatures and zoom backgrounds
A PrEP Materials Order form for brochures, booklets, and more!
If you have any questions or suggestions for PrEP Aware Week, please email us at email@example.com.
HIV resistance and hepatitis B virus (HBV) status are known. (A1)
Genotypic resistance testing results have confirmed that a patient does not have a major reverse transcriptase mutation, including the M184V/I resistance mutation. DTG/3TC is contraindicated in patients with these resistance-associated mutations. (A1)
2-drug ART not recommended for rapid ART: Dolutegravir/lamivudine (DTG/3TC) cannot be used for rapid ART because a baseline HIV genotypic resistance profile and HBV status are required prior to prescription of this regimen.
Join Dr. Asa Radix of Callen Lorde Community Health Center for this PrEP Aware Week webinar from CEI.
Date: October 29, 2021
Time: 10:00 to 11:00 AM
Learning Objectives: (1) Describe barriers to PrEP among transgender and gender-diverse people. (2) Summarize the evidence for PrEP for transgender and gender-diverse people. (3) Discuss the importance of affirming care. (4) Identify ways to overcome PrEP barriers for trans people.
Comment? Question? Suggestion?Drop us a line: firstname.lastname@example.orgWe welcome feedback and suggestions, and if you send us a question, we will get back to you as quickly as possible. Please note, however, that we cannot answer questions about the care or treatment of specific patients and cannot provide clinical advice.